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Abstract: The underlying problem for two of 
the three most common patterns of 
unexpected hospital deaths (PUHD) is 
hypoventilation1. Current methods of post-
operative respiratory monitoring give 
delayed signals and have a high false 
positive rate leading nurses to ignore 
alarms. We hypothesize there exists a 
combination of low cost sensors which are 
capable of providing real time feedback and 
alarms regarding obstructive sleep apnea 
and ventilatory depression. Such a monitor 
would be useful during space travel when 
monitoring personnel are limited following 
an injury or if astronauts were to be sedated 
during extended travel. Methods: Twenty-six 
subjects were recruited to participate in a 
study of the effects of Propofol and 
Remifentanil. Throughout the day, these 
patients were exposed to varying levels of 
both drugs simultaneously via target 
controlled infusions. These patients were 
attached to breathing and oxygen monitors 
including chest bands, pulse oximeters, 
nasal pressure sensors, C02 capnography, 
breathing microphones, and thermistors.  
The patients were then observed for types 
of apnea or ventilatory depression. Results: 
The study is currently ongoing however 
preliminary analyses of the data indicate 
multiple low cost sensors are capable of 
detecting breathing as well as obstructive 
events and apnea. Conclusion: Using only a 
combination of low cost sensors, we can 
provide real time respiratory event data to 
nurses and practitioners. 
 
INTRODUCTION & BACKGROUND 
The underlying problem for two of the three 
most common patterns of unexpected 
hospital deaths (PUHD) is hypoventilation1. 
Type II PUHD (CO2 narcosis) involves a 
reduction in respiratory rate and/or tidal 
volume, and if supplemental oxygen is 
being provided, a pulse oximeter will not 
detect the problem until the hypercarbia is 
significantly advanced and the patient is 
near respiratory arrest. Type III PUHD is 
induced by obstructive sleep apnea in the 
presence of arousal failure, and is 
recognized as a repetitive sequence of 
cyclic apneas and self-arousals which 
precede the final apnea. A pulse oximeter 
alarms with each apneic period and will 
likely be interpreted as generating many 
false positive alarms.1 The risk of opioid-
induced respiratory depression in 
postoperative patients is greatest in the first 
24 hours after initiation of opioids2, and 
opioids are the most commonly used drug 
for treating pain in the postoperative 
period.3 
These problems would be especially 
apparent in space travel where monitoring 
personnel are limited due to either sedation 
of crew members or an injury rendering the 
crew short-handed. 
Respiratory depression is caused by drug-
induced inhibition of the breathing control 
center of the brain stem. Partial to full 
airway obstruction is an anatomic problem 
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involving the soft palate, tongue base, 
and/or epiglottis, caused by drug-induced 
decreases in airway patency and muscle 
tone. Sedatives and opioids depress the 
response to elevated CO2 (reduced drive to 
breathe), worsen arousal, cause airway 
obstruction, and change sleep patterns4-8 
In the postoperative period, most adverse 
respiratory events occur during the first 24 
hours of opioid administration.2 During this 
period, pulse oximeter monitoring, 
supplemental oxygen, incentive spirometry, 
and intermittent nursing observation are the 
primary interventions used to fend off 
adverse respiratory events. For inpatient 
monitoring, pulse oximetry is often 
inadequate. On a busy hospital floor, it is 
difficult to respond to multiple remote 
advisory pulse oximetry alarms. Pulse 
oximeter alarms are ignored because they 
have a high false-positive alarm rate due to 
movement artifact and displacement.9,10 
Pulse oximetry primarily monitors 
oxygenation instead of ventilation; the SpO2 
signal is a delayed indicator for apnea or 
hypopnea, particularly when supplemental 
oxygen is given. By the time the pulse 
oximeter alarms, an apneic patient is 
already in danger of hypoxia, brain injury 
and death. 
Existing technologies may improve 
monitoring of adverse respiratory events in 
this setting, but are either costly or difficult 
to implement. For example, monitoring 
ventilation with capnography is expensive 
and it can be problematic to sample the 
exhaled gas with a face mask or nasal 
cannula in non-intubated patients.11 
Acoustic respiratory rate monitoring may be 
able to detect airway obstruction, but it is 
costly and may not have sufficient sensitivity 
to reliably detect apnea events.12 We 
suggest that there is an urgent need for a 
low cost, reliable respiratory depression 
monitoring technique that can be integrated 
with the signals from the pulse oximeter to 
give additional physiologic information about 
a patient’s sufficiency of both ventilation and 
oxygenation. 
Currently, we are exploring the value of 
integrating the information from a set of low-
cost physiologic monitors that can be 
adapted to monitoring patients in a hospital 
floor setting. In addition to the red and 
infrared component signals that comprise 
the pulse oximeter plethysmography 
waveform, we intend to integrate 
information from motion sensors on the 
finger, head, abdomen, chest wall and bed, 
temperature, pressure and carbon dioxide 
sensors embedded in a nasal cannula and 
acoustic respiratory rate via a microphone 
on the throat. We will determine from the 
tested set the fewest number and least 
costly types of sensors that can be used to 
accurately identify and quantify ventilatory 
depression and airway obstruction, provide 
reliable measures of oxygenation AND 
ventilation, provide specific alarms, and 
avoid artifact. We will evaluate this multi-
sensor set for volunteers who receive 
medications to produce ventilatory 
depression and/or partial to complete airway 
obstruction. 
Our team previously characterized various 
effects of sedatives combined with opioids 
using drug interaction models. Specifically, 
we characterized the interaction of Propofol 
and Remifentanil on metrics of airway 
obstruction and intolerable ventilatory 
depression in volunteers.8 We defined 
intolerable ventilatory depression as a 
respiratory rate less than 4 breaths per 
minute and airway compromise as either 
partial (tidal volume less than 3 mL/kg in the 
presence of a respiratory effort) or complete 
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obstruction. Respiratory compromise was 
defined as either intolerable ventilatory 
depression or airway obstruction or both.  
Using this model, predictions of respiratory 
compromise (0 to 100%) can be made for 
various dosing schemes of Propofol and 
remifentanil.8 (Figure 1).  In general, dosing 
schemes that led to high concentration of 
Propofol were more likely to produce airway 
obstruction and higher doses of 
Remifentanil were more likely to produce 
intolerable ventilatory depression.  
 
METHODS 
A 20 gauge venous catheter was placed in 
an antecubital vein under local anesthesia 
(0.2 mL of 0.5% lidocaine) for the purpose 
of hydration and drug administration.  The 
IV site was similar in all subjects. A 
maintenance infusion of 0.9% sodium 
chloride was administered at 1 ml/kg/hour 
throughout the study. Continuous infusions 
of Remifentanil and Propofol was infused 
into this peripheral IV. 
Subjects were instrumented with a 
noninvasive blood pressure cuff, ECG 
leads, pulse oximeter(s), motion sensors, 
respiratory inductance plethysmography 
"chest bands", capnography nasal cannula, 
nasal gas pressure sensor, nasal thermistor 
and an acoustic respiratory rate sensor. 
These or similar monitors were placed to 
measure respiratory rate, tidal volume, end-
tidal CO2, SpO2, blood pressure, body 
motion and heart rate. Chest and abdominal 
wall excursion were measured with the 
attached motion sensors and the respiratory 
inductance plethysmography bands. 
Changes in respiration pattern were 
displayed as real-time changes in CO2 
waveforms. A processed EEG monitor 
and/or a cerebral oximeter were optionally 
placed to record data for later analysis. A 
motion sensor was also placed on the bed. 
These devices were operational during the 
entire study day. Data from devices was 
electronically captured and recorded for 
later analysis. Continuous variables such as 
motion waveforms, pulse oximetry 
waveform, capnogram, and nasal airway 
pressure were digitized during data 
collection periods at 50-1000Hz during data 
collection periods at each target effect site 
concentration pair. Discrete variables were 
recorded every 5 seconds or as soon as 
data were available during data collection 
Figure 1: A: Dose of a drug, first as a bolus, 
then as a continuous infusion. B: effect site 
concentration (Ce) Corresponding to the 
given dose and C: Observed effect 
(sedation) for a single administered drug. 
Time points 1-5 correspond to a likelihood of 
effect in D: Effect and corresponding drug 
concentrations resulting in stated 
probabilities for respiratory compromise.  
B 
C 
D 
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periods. Examples of discrete variables 
include heart rate, SpO2, PetCO2, systolic 
blood pressure, diastolic blood pressure and 
respiratory rate. The tidal volume was 
occasionally measured with a differential 
pressure flow sensor attached to an 
anesthesia mask or mouthpiece in order to 
calibrate the respiratory inductance 
plethysmography bands. 
Each subject received Propofol and 
Remifentanil. Similar to previously collected 
data from our volunteer laboratory (Kern et 
al, 2004), each drug was administered using 
a computer controlled (Stanpump14) 
continuous infusion pump (Pump 22; 
Harvard Apparatus, Limited, Holliston, MA) 
to achieve selected target effect site 
concentrations.  The effect site 
concentration refers to the drug 
concentration at the pharmacologic site of 
action. Pharmacokinetic parameters 
published by Minto et al.15 and Schnider et 
al.16 was used for Remifentanil and Propofol 
respectively. 
We administered Propofol and Remifentanil 
pairs in a dose escalation scheme with 
small steps in order to creep up to the 
desired target effects of respiratory 
depression, airway obstruction and both 
effects while avoiding overshoot. To 
accomplish this, the Propofol was dosed in 
a range of 0.75 - 4 mcg/mL in dose 
escalation steps of approximately 0.5 
mcg/mL. Remifentanil was dosed in a range 
of 0.75 to 4.0 ng/mL in escalation steps of 
approximately 0.25-0.5 ng/mL. If overshoot 
was observed for a given target effect site 
concentration pair, the target effect site 
concentrations were lowered so 
assessments could be made during the 
target effects of respiratory depression or 
airway obstruction or both. Once the drug 
concentration pair was identified which 
resulted in the target effects for a given 
subject, the steady state drug dose was 
maintained for a period of data collection. 
To begin our analysis, we wanted to 
compare how well clinical apnea definitions 
correlated with minute volume data 
collected from our calibrated chest bands. A 
small literature search was performed for 
apnea definitions. Our data was plotted in a 
histogram according to these definitions and 
then plotted against minute volume. The 
data used in this comparison was primarily 
collected during low Propofol dosing 
schemes as we are interested in viewing the 
effectiveness of central apnea definitions.  
Our next goal was to visualize the 
effectiveness in apnea detection of different 
cranial-centric monitors with respect to the 
clinical gold standard of Capnography 
monitoring. Data was aligned temporally in 
Matlab. Per the previous analysis, we 
defined apnea as a period of at least 15 
seconds during which no breath was 
detected. Because of sample tube delay, 
the CO2 signal was shifted by 8 seconds 
before comparison to the other signals. 
Breath detection for the CO2 signal was 
done using the algorithm integrated into the 
capnometer (LoFlo, Philips, Wallingford 
CT). Breath detection for the nasal pressure 
and thermistor signals was performed using 
an algorithm we developed based on signal 
excursions above and below a baseline 
level. 
RESULTS 
A preliminary analysis of the data has 
revealed high correlation between certain 
respiratory monitors and specific breathing 
related ‘states’.  
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These breathing states are ‘normal’ 
breathing, complete airway obstruction 
(obstructive sleep apnea), partial airway 
obstruction (partial obstructive sleep apnea 
or snoring), and ventilatory depression (non-
obstructive sleep apnea) characterized by a 
breathing rate of less than four breaths per 
minute. The figure below illustrates the 
some of the primary complex breathing 
patterns that we are interested in 
monitoring.  Ventilatory depression was not 
included in the figure as it appears in the 
form of intermittent ‘normal’ breathing with 
occasionally reduced volume.  
From this data we can already see multiple 
breathing patterns once we combine signals 
such as chest or abdomen excursion 
(ventilatory effort) and nasal pressure, 
expired C02, or thermistor readings 
(ventilatory success). In column A, we see 
what we would expect for each of these 
signals under normal breathing conditions; 
The chest and abdomen are in phase with 
each other, the biphasic nasal pressure 
signal is synced with ventilatory effort, and 
the expired C02 increases at expiration.  
Column B of figure 2 illustrates how these 
signals change during airway obstruction; 
Chest and abdomen bands are out of phase 
Figure 2: Electronic signals collected during different breathing related ‘states’. The signals 
shown from top to bottom are: Chest band, abdomen band, nasal pressure, expired co2, 
and thermistor. The columns are one breath samples from the breathing states listed at the 
top of the figure. 
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with each other (paradoxical) while 
measures of ventilatory success are zeroed. 
Column C shows partial airway obstruction; 
the abdomen band becomes biphasic and 
only syncs with the chest during the latter 
half of the breath attempt where the 
obstruction was partially cleared. The lower 
magnitude nasal pressure is one indicator of 
the patient’s difficulty passing air.  
Upon review of the literature, we found 
conflicting opinions regarding the definition of 
apnea. Time since last breath is the most 
common criteria for an apnea alarm. Scientific 
studies have used anywhere from 10-30 
seconds in between breaths as the definition of 
apnea while clinical monitors can be 
programmed to detect lapses of 10-60 seconds 
in breathing. 9404 interbreath intervals were 
placed on a histogram shown in figure 3. The 
histogram follows a Gaussian distribution with 
mu=9.58 and lambda=14.10. In the histogram, 
33% of the data lies above the 10 second cutoff. 
There appears to be some correlation between 
minute volume and interbreath interval, 
however there is an extremely large deviation 
of minute volumes as indicated by the green 
error bars. Error bars are bounded by two 
standard deviations from the mean.  
Next we compared the effectiveness in 
apnea detection of the cranial-centric 
monitors shown in figure 1 (nasal pressure, 
thermistor) to the clinical Phillips monitor 
Capnography based detection. The results 
of this analysis are provided in table 1 and 
table 2. Table 1 depicts the comparison 
when the Propofol dose was low (<1 
mcg/mL). Table 2 depicts the comparison 
when Remifentanil dose was low (<1 
ng/mL). Data is shown as normalized 
percentages. True positive is define as an 
apnea flag present in both signal 1 and 
signal 2. True negative is defined no apnea 
Figure 3: Histogram of 9404 interbreath intervals. The histogram follows a Gaussian 
distribution with mu=9.58 and lambda=14.10. Minute volume is plotted on the second Y-
axis. Some correlation exists but the variance is large.   
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flag in either signal 1 or 2. False positive is 
defined as an apnea flag in signal 1 with no 
apnea flag in signal 2. False negative is 
defined as no apnea flag in signal 1 and an 
apnea flag in signal 2.   
CONCLUSION 
A low cost, accurate, and minimally sized 
respiratory monitor would be useful during 
space travel when personnel are limited 
following an injury/emergency procedure or 
if astronauts were to be sedated during 
extended voyages.  
Overall, preliminary analysis of the signals 
has been successful in proving that within 
individual patients, low cost signals exhibit 
discernible patterns during obstructive 
apnea, partial airway obstruction, and 
ventilatory depression. 
Our analysis of apnea definitions and 
correlation with minute volumes also 
indicate that there is a need for a more 
robust respiratory monitor. 
We’ve shown that there is at least moderate 
correlation between our cranial-centric 
sensors and the clinical standard of 
Capnography. Discrepancies in detection 
rate between these sensors can be 
attributed to a number of factors. To begin 
with, neither algorithm is perfect. While the 
overall number of breaths and apneas 
detected by each signal was similar, an 
incorrect breath assessment may result in 
an incorrect apnea flag. Capnography 
monitoring is especially prone to false 
positive breath detections when breathing 
rate is low—as in this study. Additionally, 
the comparison is being made between two 
sensors placed on the face and a side 
stream Capnometer. While attempts were 
made to temporally align the signal, the time 
delay is the Capnometer is dependent on 
the rate of flow through the nose. Finally, 
Signal 1 Signal 2 
True 
Positive 
True 
Negative 
False 
Positive 
False 
Negative 
Nasal Pressure Capnography 0.05 0.78 0.14 0.03 
Thermistor Capnography 0.02 0.88 0.04 0.06 
Nasal Pressure Thermistor 0.03 0.77 0.03 0.16 
Signal 1 Signal 2 
True 
Positive 
True 
Negative 
False 
Positive 
False 
Negative 
Nasal Pressure Capnography 0.13 0.66 0.15 0.07 
Thermistor Capnography 0.08 0.73 0.07 0.12 
Nasal Pressure Thermistor 0.05 0.78 0.10 0.08 
Table 1: Comparison of apnea detection in cranial centric monitors. This comparison was made 
during low Propofol dosing schemes (Propofol <1 mcg/mL).    
Table 2: Comparison of apnea detection in cranial centric monitors. This comparison was 
made during low Remifentanil dosing schemes (Remifentanil <1 mcg/mL).    
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the measured signals are fundamentally 
different. Capnometry measures gas 
concentration but is not dependent on 
volume or rate of gas flow. Nasal pressure 
and thermistor are sensitive to gas flow and 
volume and position of the cannula prongs 
in the nares. 
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